URB597 drug
Evidence from:
primary |
all sources
Related entities (10)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| URB597 | regulates | anandamide | — | 1 |
| URB597 | protective_against | cannabis withdrawal | — | 1 |
| URB597 | interacts_with | FAAH | — | 1 |
| URB597 | targets | FAAH | — | 1 |
| URB597 | risk_factor_for | glucose intolerance | — | 1 |
| URB597 | risk_factor_for | hyperglycemia | — | 1 |
| URB597 | risk_factor_for | insulin resistance | — | 1 |
| URB597 | regulates | nicotine reward | — | 1 |
| URB597 | regulates | Oleoylethanolamide | — | 1 |
| URB597 | regulates | PEA | — | 1 |
Mentioned in (8)
Papers in which this entity is mentioned.
- Sex-dependent effects of in utero cannabinoid exposure on cortical function. (2018)
- Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors. (2015)
- Endocannabinoids are conserved inhibitors of the Hedgehog pathway. (2015)
- Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies. (2014)
- Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity. (2013)
- Pharmacological treatment of cannabis dependence. (2011)
- Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors. (2011)
- Acute ethanol suppresses glutamatergic neurotransmission through endocannabinoids in hippocampal neurons. (2008)
Merged raw entities (2)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| urb597 | drug | 8 | 15 |
| faah inhibitor urb597 | drug | — | — |